Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Hemann

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Cancer Discovery|May 6, 2014
From breaking bad to worse: exploiting homologous DNA repair deficiency in cancerMichael T Hemann
Cancer Research|January 28, 2010
Nek4 status differentially alters sensitivity to distinct microtubule poisonsJason Doles, Michael T Hemann
Cell|July 29, 2017
Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal CancerAzucena Ramos, Michael T Hemann
Nature|August 14, 2019
A dynamic view of chemotherapy effectivenessYunpeng Liu, Michael T Hemann
Genes & Development|January 11, 2007
Oncogenes and senescence: breaking down in the fast laneMichael T Hemann, Masashi Narita
Cancer Research|July 21, 2011
Chemotherapeutic resistance: surviving stressful situationsLuke A Gilbert, Michael T Hemann
Cell Stem Cell|June 11, 2013
Unraveling tumor suppressor networks with in vivo RNAiChristian J Braun, Michael T Hemann
Expert Review of Anticancer Therapy|July 14, 2016
Rewiring the solid tumor epigenome for cancer therapyChristian J Braun, Michael T Hemann
Nature Biomedical Engineering|December 20, 2024
FAS-less allogeneic CAR T cellsKeith P Eidell, Michael T Hemann
Current Opinion in Genetics & Development|May 24, 2019
Functional screens identify coordinators of RNA molecule birth, life, and death as targetable cancer vulnerabilitiesChristian J Braun, Michael T Hemann
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Cancer Discovery|May 6, 2014
From breaking bad to worse: exploiting homologous DNA repair deficiency in cancerMichael T Hemann
Cancer Research|January 28, 2010
Nek4 status differentially alters sensitivity to distinct microtubule poisonsJason Doles, Michael T Hemann
Cell|July 29, 2017
Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal CancerAzucena Ramos, Michael T Hemann
Nature|August 14, 2019
A dynamic view of chemotherapy effectivenessYunpeng Liu, Michael T Hemann
Genes & Development|January 11, 2007
Oncogenes and senescence: breaking down in the fast laneMichael T Hemann, Masashi Narita
Cancer Research|July 21, 2011
Chemotherapeutic resistance: surviving stressful situationsLuke A Gilbert, Michael T Hemann
Cell Stem Cell|June 11, 2013
Unraveling tumor suppressor networks with in vivo RNAiChristian J Braun, Michael T Hemann
Expert Review of Anticancer Therapy|July 14, 2016
Rewiring the solid tumor epigenome for cancer therapyChristian J Braun, Michael T Hemann
Nature Biomedical Engineering|December 20, 2024
FAS-less allogeneic CAR T cellsKeith P Eidell, Michael T Hemann
Current Opinion in Genetics & Development|May 24, 2019
Functional screens identify coordinators of RNA molecule birth, life, and death as targetable cancer vulnerabilitiesChristian J Braun, Michael T Hemann
Pageof 12